FDA Brief

Warning letters Drugs

FDA warning letter to

ATLRx, Inc.

High riskIssued May 4, 2022Posted May 4, 2022Center for Drug Evaluation and Research | CDER

FDA warned ATLRx that its CBD and Delta-8 THC products are unapproved drugs with illegal disease claims.

What happened

FDA reviewed www.atlrx.com in February 2022 and ATLRx's Twitter, Facebook, and Instagram accounts, and found claims that CBD and Delta-8 THC products treat conditions such as cancer, pain, anxiety, seizures, and nausea. FDA also found CBD and Delta-8 THC added to conventional foods and CBD in pet products. The letter describes a website and social media review, not an inspection.

What FDA found

  1. CBD and Delta-8 THC products for humans are unapproved new drugs because their labeling claims they treat diseases and no FDA-approved application is in effect.

    FD&C Act sections 505(a) and 301(d), 21 U.S.C. 355(a), 331(d)
  2. The human CBD and Delta-8 THC products are misbranded because their labeling lacks adequate directions for a layperson to use them safely.

    FD&C Act section 502(f)(1), 21 U.S.C. 352(f)(1)
  3. CBD and Delta-8 THC in conventional foods such as gummies and chocolates make those foods adulterated because they contain an unsafe food additive or a prohibited CBD food ingredient.

    FD&C Act sections 402(a)(2)(C)(i), 301(ll), and 409(a), 21 U.S.C. 342(a)(2)(C)(i), 331(ll), 348(a)
  4. CBD pet oil tincture and pet treats are unapproved new animal drugs and are unsafe/adulterated because they lack FDA approval or index listing.

    FD&C Act sections 512(a) and 501(a)(5), 21 U.S.C. 360b(a), 351(a)(5)
  5. CBD added to animal food is an unsafe food additive and makes the animal food adulterated.

    FD&C Act sections 402(a)(2)(C)(i) and 409(a), 21 U.S.C. 342(a)(2)(C)(i), 348(a)
  6. CBD salve, lotion, and hand sanitizer cannot be legally marketed as nonprescription drugs without an approved application.

    FD&C Act section 505G; 21 CFR 330.1(e)

What FDA wants

FDA asks ATLRx to correct the violations and respond in writing; the excerpt does not state a response deadline.

Who should pay attention

  • companies selling CBD or Delta-8 THC products with health claims
  • brands selling CBD or Delta-8 THC foods and pet products
  • retailers and distributors of hemp-derived cannabinoid edibles

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Natuzem

    FDA warned Mexico-based Natuzem for selling unapproved new drugs, including Reumofan Plus, to U.S. consumers online.

    High risk
  2. RonanRx, Inc. dba RonanRx

    FDA says RonanRx's website and X posts misbrand compounded semaglutide and tirzepatide with false or misleading claims.

    Low
  3. Calibrate IV Hydration

    FDA told Calibrate IV Hydration its umbilical cord and exosome IV products are unapproved drugs and unlicensed biologics.

    High risk
  4. Best Chinese Medicines LLC

    FDA warned Best Chinese Medicines LLC that five herbal products sold online are unapproved new drugs because their labeling claims to treat diseases.

    High risk